Please login to the form below

Not currently logged in
Email:
Password:

Stage Cell Therapeutics

This page shows the latest Stage Cell Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Juno boosts CAR-T presence with $80m German acquisition

Juno boosts CAR-T presence with $80m German acquisition

Juno boosts CAR-T presence with $80m German acquisition. Stage Cell Therapeutics will contribute in process development and manufacturing. ... Juno Therapeutics has laid claim to another piece of the immuno-oncology territory by buying Germany's Stage

Latest news

  • Going for gold

    Cell Therapeutics is conducting late-stage clinical development with its solvent-free formulation ñ paclitaxel poliglumex (Xyotax). ... The paclitaxel then releases from the polymer and becomes active. Cell Therapeutics is currently conducting phase III

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals in May 2015 Pharma deals in May 2015

    Last in its hat trick of deals this month was Juno's acquisition of Stage Cell Therapeutics for an initial payment of $59m with $150m in success payments. ... 900. Editas/Juno Therapeutics. Collaboration. Development of next generation CAR-T and TRC cell

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics